Novo Nordisk Enters a New License Agreement for the Enterprise Execution Software Howwe®
Non-regulatory pressrelease
Novo Nordisk, a global healthcare company committed to preventing and treating diabetes, obesity, and other serious chronic diseases, has entered into a new license agreement with Howwe Technologies, an enterprise execution software provider. The partnership, which began in 2017, generated a return on investment of 20 times for Novo Nordisk already in 2018. The license…